Delivery Order SPE2DR25D3111-SPE2DR26FF3TN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BOTOX Cosmetic 50 unit vials under a firm fixed-price contract. The order, valued at $1,432.38, was competitively awarded without set-aside designation and is scheduled for completion by December 23, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100-unit vials, with a ceiling value of $2,153.40 and an ultimate completion date of June 24, 2025. This non-competitive delivery order carries firm fixed pricing and represents a competitive award under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is...
- The Defense Logistics Agency awarded a $2,595.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100 unit vials, with an ultimate completion date of December 24, 2025. This non-set-aside contract represents a competitively awarded delivery order issued under AmerisourceBergen's existing federal pharmaceutical supply agreements. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $5,191.32 delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100 unit vials. The contract carries a firm fixed price structure with no set-aside designation and is scheduled for completion by December 12, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026, which serves as the primary vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,460.88 to AmerisourceBergen Drug Corp for the supply of Botox Cosmetic 100 Unit Vials under contract 4570309502. This firm fixed-price delivery order, awarded on December 16, 2025, with an ultimate completion date of January 8, 2026, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a $3,460.88 delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100 Unit Vials, with an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a $15,639.75 delivery order to AmerisourceBergen Drug Corp for the supply of BOTOX Cosmetic 100 unit vials. This competitively awarded, firm fixed-price contract with no set-aside designation is expected to be completed by October 3, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a $2,624.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100 unit vials, with an ultimate completion date of July 11, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with a ceiling value of $1,297.83 and an ultimate completion date of December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,460.88 to AmerisourceBergen Drug Corp for the supply of Botox Cosmetic 100 unit vials. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract contains no set-aside designation. This...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3TNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,595.66 to AmerisourceBergen Drug Corp for the supply of Botox Cosmetic 100 unit vials. This non-competitive, firm fixed-price delivery order was awarded on December 29, 2025, with an ultimate completion date of January 21, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999.999 billion and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively selected to serve as a prime contractor for the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs. This particular delivery order represents one component of the company's ongoing pharmaceutical support services to federal healthcare systems, including the Defense Health Agency and other government medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/28/25 |